US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Warrior Met Coal LLC

91.80

-0.9200-0.99%

Pre-market: 92.490.6900+0.75%04:42 EDT

Volume:612.18K

Turnover:56.42M

Market Cap:4.83B

PE:22.07

High:95.91

Open:94.14

Low:91.47

Close:92.72

52wk High:111.42

52wk Low:60.70

Shares:52.57M

Float Shares:51.78M

Volume Ratio:0.84

T/O Rate:1.18%

Dividend:0.32

Dividend Rate:0.35%

EPS(TTM):4.16

EPS(LYR):1.08

ROE:10.04%

ROA:5.17%

PB:2.11

PE(LYR):85.00

Loading ...

Overview Company News Filings

Sirtex Medical's DOORwaY90 Study Demonstrates 100% Local Tumor Control with SIR-Spheres®, Setting a New Benchmark in Y-90 for HCC

Warrior Met Coal (HCC) Valuation Check After Sector Weakness And Analyst Downgrade

Simply Wall St.

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Biliary Tract Cancer Following Positive Safety and Preliminary Efficacy Results

Warrior Met Coal (HCC) Receives a Hold from RBC Capital

Press Release: Warrior Sets Date for First Quarter 2026 Earnings Announcement and Investor Conference Call

Do Analyst Downgrades And Weaker Coal Outlook Change The Bull Case For Warrior Met Coal (HCC)?

Simply Wall St.

Press Release: Adagene Reports Full Year 2025 Financial Results and Provides Corporate Update

Press Release: Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update

Coal Stocks Have (Mostly) Benefited from the Iran War. This One Is Falling Like a Rock. -- Barrons.com

Press Release: Harbour BioMed Reports Full Year 2025 Financial Results: Sustained Global Collaboration Underpins Long-Term Growth

Can-Fite’s Partner Vetbiolix Completes Enrollment in Phase 2 Osteoarthritis Study in Dogs Treated with Piclidenoson; Data Expected in Q3 2026

Warrior Met Coal Is Maintained at Buy by UBS

Warrior Met Coal price target raised to $105 from $101 at UBS

Press Release: Akeso Reports Full-Year 2025 Financial Results

Press Release: CStone Announces 2025 Annual Results: Accelerated Expansion of Global Commercial Footprint and Efficient Advancement of Innovation Pipeline 2.0

Press Release: Can-Fite Reports 2025 Financial Results and Ongoing Clinical Progress Highlighting Positive Data in Phase 2a Pancreatic cancer and 9 Years Cancer-Free Survival in Liver Cancer Patient

Press Release: Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/HCC/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"HCC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HCC\",,,,,undefined,":{"symbol":"HCC","market":"US","secType":"STK","nameCN":"Warrior Met Coal LLC","latestPrice":91.8,"timestamp":1789675200000,"preClose":92.72,"halted":0,"volume":612179,"hourTrading":{"tag":"盘前","latestPrice":92.49,"preClose":91.8,"latestTime":"04:42 EDT","volume":10,"amount":922.8700000000001,"timestamp":1789720963530,"change":0.69,"changeRate":0.007516,"amplitude":0.007625},"delay":0,"changeRate":-0.00992234685073341,"floatShares":51775204,"shares":52570156,"eps":4.16,"marketStatus":"Pre-Mkt","change":-0.92,"latestTime":"09-18 05:37:03 EDT","open":94.14,"high":95.91,"low":91.465,"amount":56419634.876210004,"amplitude":0.04794,"askPrice":107.18,"askSize":56,"bidPrice":84.41,"bidSize":100,"shortable":3,"etf":0,"ttmEps":4.16,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789738200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":720248400000,"exchange":"NYSE","adjPreClose":91.8,"dividendRate":0.003486,"preHourTrading":{"tag":"盘前","latestPrice":92.49,"preClose":91.8,"latestTime":"04:42 EDT","volume":10,"amount":922.8700000000001,"timestamp":1789720963530,"change":0.69,"changeRate":0.007516,"amplitude":0.007625},"postHourTrading":{"tag":"盘后","latestPrice":91.8,"preClose":91.8,"latestTime":"19:30 EDT","volume":92082,"amount":8453127.6,"timestamp":1789687809159,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8435222241331026,"impliedVol":0.513,"impliedVolPercentile":0.308},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HCC\",,,,,undefined,":{"symbol":"HCC","floatShares":51775204,"roa":"5.17%","roe":"10.04%","lyrEps":1.08,"volumeRatio":0.8435222241331026,"shares":52570156,"dividePrice":0.32,"high":95.91,"amplitude":0.04794,"preClose":92.72,"low":91.465,"week52Low":60.7,"pbRate":"2.11","psRate":"2.87","week52High":111.42,"institutionHeld":0.9048,"latestPrice":91.8,"committee":0.282051,"eps":4.16,"divideRate":0.003486,"volume":612179,"delay":0,"ttmEps":4.16,"open":94.14,"prevYearClose":88.17,"prevWeekClose":97.77,"prevMonthClose":108.24,"prevQuarterClose":81.16,"fiveDayClose":101.65,"twentyDayClose":105.05,"sixtyDayClose":86.11,"dividendPayoutRate":0.29508426500042423,"dividendFrequency":"Q","dividendGrowthYears":0,"dividendGrowthRate":-0.6097560975609756,"fiveYearAvgDividendRate":0.017993903852534982},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HCC\",params:#limit:5,,,undefined,":[{"date":"2026-08-10","symbol":"HCC","amount":0.08,"announcedDate":"2026-07-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-10","defaultRemindTime":1786368600000,"name":"Warrior Met Coal LLC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-17","payableDate":"2026-08-10","currency":"USD","dateTimestamp":1786334400000,"payDate":"2026-08-17"},{"market":"US","date":"2026-08-05","symbol":"HCC","fiscalQuarterEnding":"2026/06","expectedEps":1.54,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":1.65},{"date":"2026-05-01","symbol":"HCC","amount":0.08,"announcedDate":"2026-04-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-01","defaultRemindTime":1777642200000,"name":"Warrior Met Coal LLC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-07","payableDate":"2026-05-01","currency":"USD","dateTimestamp":1777608000000,"payDate":"2026-05-07"},{"date":"2026-04-30","symbol":"HCC","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2026/03","expectedEps":1.21,"defaultRemindTime":1777579200000,"name":null,"time":"Post-Mkt","dateTimestamp":1777521600000,"actualEps":null},{"date":"2026-02-23","symbol":"HCC","amount":0.08,"announcedDate":"2026-02-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-23","defaultRemindTime":1771857000000,"name":"Warrior Met Coal LLC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-02","payableDate":"2026-02-23","currency":"USD","dateTimestamp":1771822800000,"payDate":"2026-03-02"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HCC\",market:\"US\",,,undefined,":[{"executeDate":"2017-05-25","recordDate":"2017-05-30","paymentDate":"2017-06-13","value":0.05,"currency":"USD"},{"executeDate":"2017-08-10","recordDate":"2017-08-14","paymentDate":"2017-08-23","value":0.05,"currency":"USD"},{"executeDate":"2017-11-02","recordDate":"2017-11-03","paymentDate":"2017-11-10","value":0.05,"currency":"USD"},{"executeDate":"2017-11-24","recordDate":"2017-11-13","paymentDate":"2017-11-22","value":11.21,"currency":"USD"},{"executeDate":"2018-02-22","recordDate":"2018-02-23","paymentDate":"2018-03-02","value":0.05,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HCC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.3333,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":9,"updateTime":1784952000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HCC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HCC","date":"2026-09-17","current":22.067308,"percent":0.726901,"low":-75.380251,"twenty":2.849453,"median":7.376569,"eighty":30.314849,"high":153.112896,"avg":18.152212,"sd":40.018027,"marketCap":4895809506},"quantilePoints":[{"date":"2021-09-24","current":-14.990419,"twenty":1.491466,"median":2.590275,"eighty":3.69463,"marketCap":1112004248},{"date":"2021-10-01","current":-17.665547,"twenty":1.437809,"median":2.583354,"eighty":3.691387,"marketCap":1310447909},{"date":"2021-10-08","current":-18.62887,"twenty":1.417229,"median":2.579596,"eighty":3.688084,"marketCap":1381908192},{"date":"2021-10-15","current":-18.317003,"twenty":-4.135408,"median":2.572321,"eighty":3.686335,"marketCap":1358773568},{"date":"2021-10-22","current":-17.603173,"twenty":-4.510213,"median":2.5394,"eighty":3.684309,"marketCap":1305820985},{"date":"2021-10-29","current":-16.612128,"twenty":-4.706327,"median":2.532428,"eighty":3.680121,"marketCap":1232304291},{"date":"2021-11-05","current":-54.762812,"twenty":-4.859084,"median":2.521967,"eighty":3.677059,"marketCap":1167543151},{"date":"2021-11-12","current":-54.979838,"twenty":-4.941339,"median":2.515293,"eighty":3.676527,"marketCap":1172170138},{"date":"2021-11-19","current":-50.808122,"twenty":-5.127728,"median":2.433754,"eighty":3.674604,"marketCap":1083229158},{"date":"2021-11-26","current":-51.362743,"twenty":-5.252528,"median":2.414858,"eighty":3.674123,"marketCap":1095053682},{"date":"2021-12-03","current":-53.123062,"twenty":-5.611529,"median":2.40502,"eighty":3.665747,"marketCap":1132583691},{"date":"2021-12-10","current":-54.232305,"twenty":-5.755373,"median":2.350665,"eighty":3.656822,"marketCap":1156232737},{"date":"2021-12-17","current":-57.415348,"twenty":-10.37185,"median":2.326995,"eighty":3.653327,"marketCap":1224095219},{"date":"2021-12-23","current":-61.56295,"twenty":-10.599286,"median":2.309178,"eighty":3.651736,"marketCap":1312522089},{"date":"2021-12-31","current":-61.997001,"twenty":-10.714311,"median":2.30567,"eighty":3.650401,"marketCap":1321776064},{"date":"2022-01-07","current":-62.551622,"twenty":-10.856785,"median":2.304,"eighty":3.648657,"marketCap":1333600587},{"date":"2022-01-14","current":-66.55454,"twenty":-11.03063,"median":2.299612,"eighty":3.646023,"marketCap":1418942799},{"date":"2022-01-21","current":-62.334597,"twenty":-11.190096,"median":2.295173,"eighty":3.645248,"marketCap":1328973600},{"date":"2022-01-28","current":-63.443839,"twenty":-11.25153,"median":2.293323,"eighty":3.644889,"marketCap":1352622647},{"date":"2022-02-04","current":-69.327646,"twenty":-11.379626,"median":2.286804,"eighty":3.642707,"marketCap":1478065416},{"date":"2022-02-11","current":-73.981641,"twenty":-11.424067,"median":2.276675,"eighty":3.635881,"marketCap":1577288590},{"date":"2022-02-18","current":-75.380251,"twenty":-11.527328,"median":2.273681,"eighty":3.62589,"marketCap":1607106953},{"date":"2022-02-25","current":10.752414,"twenty":-11.5221,"median":2.276675,"eighty":3.645162,"marketCap":1622334987},{"date":"2022-03-04","current":13.090637,"twenty":-11.476351,"median":2.285809,"eighty":3.650617,"marketCap":1975128468},{"date":"2022-03-11","current":14.234148,"twenty":-11.443674,"median":2.292953,"eighty":3.674123,"marketCap":2147662506},{"date":"2022-03-18","current":13.142137,"twenty":-11.424067,"median":2.295173,"eighty":3.679184,"marketCap":1982898730},{"date":"2022-03-25","current":13.066882,"twenty":-11.424067,"median":2.299612,"eighty":3.690894,"marketCap":1971544287},{"date":"2022-04-01","current":12.971104,"twenty":-11.417532,"median":2.304,"eighty":3.702437,"marketCap":1957093177},{"date":"2022-04-08","current":12.868485,"twenty":-11.39139,"median":2.30567,"eighty":3.733802,"marketCap":1941609845},{"date":"2022-04-14","current":13.569718,"twenty":-11.386161,"median":2.308491,"eighty":3.738166,"marketCap":2047412614},{"date":"2022-04-22","current":11.298406,"twenty":-11.36394,"median":2.326995,"eighty":3.75363,"marketCap":1704714864},{"date":"2022-04-29","current":11.654154,"twenty":-11.348255,"median":2.350665,"eighty":3.7679,"marketCap":1758390415},{"date":"2022-05-06","current":5.191508,"twenty":-11.309043,"median":2.40502,"eighty":3.798629,"marketCap":1653417395},{"date":"2022-05-13","current":5.197995,"twenty":-11.263294,"median":2.414858,"eighty":3.813721,"marketCap":1655483521},{"date":"2022-05-20","current":5.376398,"twenty":-11.243687,"median":2.472508,"eighty":3.823204,"marketCap":1712301988},{"date":"2022-05-27","current":5.592102,"twenty":-11.241073,"median":2.517292,"eighty":3.828494,"marketCap":1781000680},{"date":"2022-06-03","current":5.866193,"twenty":-11.217545,"median":2.521967,"eighty":3.839442,"marketCap":1868294507},{"date":"2022-06-10","current":5.890521,"twenty":-11.197938,"median":2.532428,"eighty":3.86219,"marketCap":1876042480},{"date":"2022-06-17","current":5.476952,"twenty":-11.179639,"median":2.5394,"eighty":3.887139,"marketCap":1744326943},{"date":"2022-06-24","current":5.214214,"twenty":-11.122126,"median":2.569547,"eighty":3.909261,"marketCap":1660648836},{"date":"2022-07-01","current":4.816863,"twenty":-11.046315,"median":2.578972,"eighty":4.004025,"marketCap":1534098614},{"date":"2022-07-08","current":4.666032,"twenty":-11.034551,"median":2.581956,"eighty":4.305553,"marketCap":1486061183},{"date":"2022-07-15","current":4.907686,"twenty":-11.001874,"median":2.584621,"eighty":4.638461,"marketCap":1563024379},{"date":"2022-07-22","current":4.828216,"twenty":-10.933904,"median":2.593675,"eighty":4.813944,"marketCap":1537714335},{"date":"2022-07-29","current":5.178533,"twenty":-10.929983,"median":2.601117,"eighty":4.897306,"marketCap":1649285143},{"date":"2022-08-05","current":2.424599,"twenty":-10.885542,"median":2.602918,"eighty":4.942718,"marketCap":1503634374},{"date":"2022-08-12","current":2.78275,"twenty":-10.769209,"median":2.601117,"eighty":4.897306,"marketCap":1725744570},{"date":"2022-08-19","current":2.883532,"twenty":-10.762674,"median":2.606673,"eighty":4.850273,"marketCap":1788245347},{"date":"2022-08-26","current":2.90602,"twenty":-10.753524,"median":2.613044,"eighty":4.828216,"marketCap":1802191801},{"date":"2022-09-02","current":2.655315,"twenty":-10.726075,"median":2.623886,"eighty":4.825945,"marketCap":1646714663},{"date":"2022-09-09","current":2.606173,"twenty":-10.679019,"median":2.621717,"eighty":4.816863,"marketCap":1616239078},{"date":"2022-09-16","current":2.333812,"twenty":-10.659413,"median":2.607733,"eighty":4.802266,"marketCap":1447332022},{"date":"2022-09-23","current":2.248855,"twenty":-10.646342,"median":2.605949,"eighty":4.683872,"marketCap":1394645418},{"date":"2022-09-30","current":2.368795,"twenty":-10.633271,"median":2.601176,"eighty":4.666032,"marketCap":1469027473},{"date":"2022-10-07","current":2.692797,"twenty":-10.548309,"median":2.602947,"eighty":4.640083,"marketCap":1669959853},{"date":"2022-10-14","current":2.765261,"twenty":-10.509096,"median":2.606173,"eighty":4.631973,"marketCap":1714898457},{"date":"2022-10-21","current":3.075936,"twenty":-10.450277,"median":2.610389,"eighty":4.409781,"marketCap":1907566266},{"date":"2022-10-28","current":3.08843,"twenty":-10.319566,"median":2.623886,"eighty":4.385454,"marketCap":1915314301},{"date":"2022-11-04","current":2.888992,"twenty":-6.057648,"median":2.626492,"eighty":4.335369,"marketCap":1964901726},{"date":"2022-11-11","current":2.590524,"twenty":-5.933659,"median":2.635068,"eighty":4.24592,"marketCap":1761903204},{"date":"2022-11-18","current":2.532805,"twenty":-5.933659,"median":2.635068,"eighty":4.24592,"marketCap":1722646492},{"date":"2022-11-25","current":2.695329,"twenty":-5.2582,"median":2.638393,"eighty":4.24592,"marketCap":1833185128},{"date":"2022-12-02","current":2.967976,"twenty":-5.2582,"median":2.645964,"eighty":4.24592,"marketCap":2018621437},{"date":"2022-12-09","current":2.695329,"twenty":-5.2582,"median":2.656981,"eighty":4.24592,"marketCap":1833185128},{"date":"2022-12-16","current":2.63761,"twenty":-5.2582,"median":2.657169,"eighty":4.24592,"marketCap":1793928416},{"date":"2022-12-23","current":2.75153,"twenty":-5.18405,"median":2.661998,"eighty":4.24592,"marketCap":1871408768},{"date":"2022-12-30","current":2.630775,"twenty":1.404132,"median":2.662192,"eighty":4.24592,"marketCap":1789279595},{"date":"2023-01-06","current":2.629256,"twenty":1.404132,"median":2.658582,"eighty":4.24592,"marketCap":1788246524},{"date":"2023-01-13","current":2.614826,"twenty":1.404132,"median":2.654586,"eighty":4.24592,"marketCap":1778432346},{"date":"2023-01-20","current":2.909498,"twenty":1.404132,"median":2.654586,"eighty":4.24592,"marketCap":1978848190},{"date":"2023-01-27","current":2.806211,"twenty":1.404132,"median":2.654586,"eighty":4.24592,"marketCap":1908599337},{"date":"2023-02-03","current":2.875322,"twenty":1.404132,"median":2.654586,"eighty":4.24592,"marketCap":1955604084},{"date":"2023-02-10","current":2.913295,"twenty":1.404132,"median":2.654586,"eighty":4.24592,"marketCap":1981430868},{"date":"2023-02-17","current":3.373053,"twenty":1.404132,"median":2.654586,"eighty":4.24592,"marketCap":2163132093},{"date":"2023-02-24","current":2.987654,"twenty":1.404132,"median":2.654586,"eighty":4.24592,"marketCap":1915976338},{"date":"2023-03-03","current":3.436207,"twenty":1.404132,"median":2.654586,"eighty":4.24592,"marketCap":2203632406},{"date":"2023-03-10","current":3.066191,"twenty":1.404132,"median":2.654586,"eighty":4.24592,"marketCap":1966342111},{"date":"2023-03-17","current":2.689033,"twenty":1.404132,"median":2.654586,"eighty":4.24592,"marketCap":1724471348},{"date":"2023-03-24","current":2.800096,"twenty":1.404132,"median":2.654586,"eighty":4.24592,"marketCap":1795696122},{"date":"2023-03-31","current":2.976014,"twenty":1.406003,"median":2.65495,"eighty":4.216104,"marketCap":1908512005},{"date":"2023-04-06","current":2.906296,"twenty":1.406003,"median":2.65495,"eighty":4.216104,"marketCap":1863801563},{"date":"2023-04-14","current":3.133287,"twenty":1.404132,"median":2.654586,"eighty":4.24592,"marketCap":2009370443},{"date":"2023-04-21","current":3.063568,"twenty":1.404132,"median":2.656974,"eighty":4.24592,"marketCap":1964660001},{"date":"2023-04-28","current":2.771722,"twenty":1.404132,"median":2.657169,"eighty":4.24592,"marketCap":1777500012},{"date":"2023-05-05","current":2.740192,"twenty":1.404132,"median":2.658582,"eighty":4.24592,"marketCap":1856003230},{"date":"2023-05-19","current":2.709489,"twenty":-3.288715,"median":2.658582,"eighty":4.355403,"marketCap":1835207675},{"date":"2023-05-26","current":2.572864,"twenty":-3.288715,"median":2.658582,"eighty":4.355403,"marketCap":1742667458},{"date":"2023-06-02","current":2.563653,"twenty":-3.288715,"median":2.656144,"eighty":4.355403,"marketCap":1736428792},{"date":"2023-06-09","current":2.740192,"twenty":-3.288715,"median":2.656144,"eighty":4.355403,"marketCap":1856003230},{"date":"2023-06-16","current":2.770894,"twenty":-3.288715,"median":2.656977,"eighty":4.355403,"marketCap":1876798784},{"date":"2023-06-23","current":2.906753,"twenty":-5.632332,"median":2.661998,"eighty":4.36542,"marketCap":1968819112},{"date":"2023-06-30","current":2.978903,"twenty":-7.975949,"median":2.667532,"eighty":4.375437,"marketCap":2017688665},{"date":"2023-07-07","current":2.974298,"twenty":-7.975949,"median":2.669576,"eighty":4.375437,"marketCap":2014569332},{"date":"2023-07-14","current":3.000395,"twenty":-7.975949,"median":2.674943,"eighty":4.375437,"marketCap":2032245553},{"date":"2023-07-21","current":3.103248,"twenty":-7.975949,"median":2.685979,"eighty":4.375437,"marketCap":2101910660},{"date":"2023-07-28","current":3.259063,"twenty":-7.975949,"median":2.685979,"eighty":4.375437,"marketCap":2207448099},{"date":"2023-08-04","current":4.300459,"twenty":-7.975949,"median":2.689283,"eighty":4.404916,"marketCap":1988652498},{"date":"2023-08-11","current":4.570433,"twenty":-7.975949,"median":2.689283,"eighty":4.59563,"marketCap":2113495971},{"date":"2023-08-18","current":4.468067,"twenty":-7.975949,"median":2.697608,"eighty":4.598779,"marketCap":2066159488},{"date":"2023-08-25","current":4.417447,"twenty":-7.975949,"median":2.70915,"eighty":4.598779,"marketCap":2042751336},{"date":"2023-09-01","current":4.450069,"twenty":-7.975949,"median":2.713487,"eighty":4.598779,"marketCap":2057836589},{"date":"2023-09-08","current":4.685171,"twenty":-7.975949,"median":2.718459,"eighty":4.660842,"marketCap":2166554448},{"date":"2023-09-15","current":5.306111,"twenty":-7.975949,"median":2.726847,"eighty":4.770664,"marketCap":2453694437},{"date":"2023-09-22","current":5.214995,"twenty":-7.975949,"median":2.726847,"eighty":4.828216,"marketCap":2411559765},{"date":"2023-09-29","current":5.743694,"twenty":-7.975949,"median":2.726847,"eighty":4.944336,"marketCap":2656044900},{"date":"2023-10-06","current":5.586209,"twenty":-7.975949,"median":2.726847,"eighty":5.01406,"marketCap":2583219541},{"date":"2023-10-13","current":5.506342,"twenty":-7.975949,"median":2.726847,"eighty":5.085439,"marketCap":2546286680},{"date":"2023-10-20","current":5.371355,"twenty":-7.975949,"median":2.726847,"eighty":5.164092,"marketCap":2483864943},{"date":"2023-10-27","current":5.320735,"twenty":-10.37185,"median":2.7187,"eighty":5.183723,"marketCap":2460456792},{"date":"2023-11-03","current":5.632314,"twenty":-10.37185,"median":2.7187,"eighty":5.218575,"marketCap":2531201427},{"date":"2023-11-10","current":5.363861,"twenty":-10.37185,"median":2.7187,"eighty":5.29291,"marketCap":2410556891},{"date":"2023-11-17","current":5.898627,"twenty":-10.37185,"median":2.7187,"eighty":5.335852,"marketCap":2650884316},{"date":"2023-11-24","current":6.40214,"twenty":-10.37185,"median":2.7187,"eighty":5.365059,"marketCap":2877166631},{"date":"2023-12-01","current":6.478535,"twenty":-10.37185,"median":2.72267,"eighty":5.38029,"marketCap":2911499120},{"date":"2023-12-08","current":6.762123,"twenty":-10.345708,"median":2.726847,"eighty":5.40405,"marketCap":3038945481},{"date":"2023-12-15","current":6.477378,"twenty":-10.345708,"median":2.726847,"eighty":5.427885,"marketCap":2910978931},{"date":"2023-12-22","current":7.108216,"twenty":-10.37185,"median":2.72267,"eighty":5.478809,"marketCap":3194482061},{"date":"2023-12-29","current":7.112846,"twenty":-10.397993,"median":2.720685,"eighty":5.489704,"marketCap":3196562818},{"date":"2024-01-05","current":7.608257,"twenty":-10.424135,"median":2.7187,"eighty":5.542798,"marketCap":3419203808},{"date":"2024-01-12","current":7.309621,"twenty":-10.424135,"median":2.7187,"eighty":5.590923,"marketCap":3284994987},{"date":"2024-01-19","current":7.808504,"twenty":-10.450277,"median":2.718459,"eighty":5.669951,"marketCap":3509196545},{"date":"2024-01-26","current":7.412639,"twenty":-10.424135,"median":2.7187,"eighty":5.709874,"marketCap":3331291828},{"date":"2024-02-02","current":7.465884,"twenty":-10.424135,"median":2.7187,"eighty":5.766422,"marketCap":3355220533},{"date":"2024-02-09","current":6.990151,"twenty":-10.424135,"median":2.7187,"eighty":5.885655,"marketCap":3141422759},{"date":"2024-02-16","current":6.418502,"twenty":-10.424135,"median":2.7187,"eighty":6.101684,"marketCap":3072081326},{"date":"2024-02-23","current":6.286398,"twenty":-10.424135,"median":2.731024,"eighty":6.221043,"marketCap":3008852573},{"date":"2024-03-01","current":6.219801,"twenty":-10.397993,"median":2.739743,"eighty":6.294914,"marketCap":2976976920},{"date":"2024-03-08","current":6.701206,"twenty":-10.397993,"median":2.752304,"eighty":6.394269,"marketCap":3207391753},{"date":"2024-03-15","current":5.794309,"twenty":-10.397993,"median":2.757333,"eighty":6.40214,"marketCap":2773324387},{"date":"2024-03-22","current":6.171272,"twenty":-10.397993,"median":2.771308,"eighty":6.40214,"marketCap":2953749979},{"date":"2024-03-28","current":6.782062,"twenty":-10.397993,"median":2.782329,"eighty":6.419638,"marketCap":3246091735},{"date":"2024-04-05","current":6.157068,"twenty":-10.424135,"median":2.792386,"eighty":6.450017,"marketCap":2946951333},{"date":"2024-04-12","current":6.902254,"twenty":-10.424135,"median":2.806211,"eighty":6.478304,"marketCap":3303618735},{"date":"2024-04-19","current":7.227863,"twenty":-10.424135,"median":2.821174,"eighty":6.550936,"marketCap":3459464608},{"date":"2024-04-26","current":7.599363,"twenty":-10.397993,"median":2.831103,"eighty":6.604876,"marketCap":3637275337},{"date":"2024-05-03","current":7.904106,"twenty":-10.397993,"median":2.843363,"eighty":6.650657,"marketCap":3425173301},{"date":"2024-05-10","current":7.957211,"twenty":-10.397993,"median":2.851831,"eighty":6.739488,"marketCap":3448185612},{"date":"2024-05-17","current":7.69893,"twenty":-10.397993,"median":2.862085,"eighty":6.836555,"marketCap":3336262099},{"date":"2024-05-24","current":7.872726,"twenty":-10.397993,"median":2.873803,"eighty":6.918183,"marketCap":3411575117},{"date":"2024-05-31","current":8.030833,"twenty":-10.397993,"median":2.87874,"eighty":7.041081,"marketCap":3480089043},{"date":"2024-06-07","current":8.312045,"twenty":-10.397993,"median":2.890347,"eighty":7.110994,"marketCap":3601949691},{"date":"2024-06-14","current":7.809967,"twenty":-10.424135,"median":2.899357,"eighty":7.20537,"marketCap":3384378749},{"date":"2024-06-21","current":8.021177,"twenty":-10.450277,"median":2.908126,"eighty":7.318881,"marketCap":3475904987},{"date":"2024-06-28","current":7.420132,"twenty":-10.485568,"median":2.914426,"eighty":7.344392,"marketCap":3215447466},{"date":"2024-07-05","current":8.845502,"twenty":-10.485568,"median":2.921699,"eighty":7.399675,"marketCap":3833118816},{"date":"2024-07-12","current":8.297562,"twenty":-10.485568,"median":2.930616,"eighty":7.467301,"marketCap":3595673606},{"date":"2024-07-15","current":8.5486,"twenty":-10.485568,"median":2.931522,"eighty":7.489052,"marketCap":3704459076},{"date":"2024-08-02","current":8.040485,"twenty":-10.635885,"median":2.949925,"eighty":7.544826,"marketCap":3392746863},{"date":"2024-08-09","current":7.544899,"twenty":-10.635885,"median":2.968066,"eighty":7.555471,"marketCap":3183630662},{"date":"2024-08-16","current":7.220094,"twenty":-10.635885,"median":2.978269,"eighty":7.601142,"marketCap":3046576565},{"date":"2024-08-23","current":7.176704,"twenty":-10.635885,"median":3.000593,"eighty":7.601142,"marketCap":3028267812},{"date":"2024-08-30","current":7.621762,"twenty":-10.635885,"median":3.027721,"eighty":7.610958,"marketCap":3216063311},{"date":"2024-09-06","current":6.658504,"twenty":-10.635885,"median":3.039541,"eighty":7.610958,"marketCap":2809608986},{"date":"2024-09-13","current":6.653545,"twenty":-10.635885,"median":3.054202,"eighty":7.610958,"marketCap":2807516557},{"date":"2024-09-20","current":6.839502,"twenty":-10.635885,"median":3.066906,"eighty":7.610958,"marketCap":2885982643},{"date":"2024-09-27","current":7.775486,"twenty":-10.635885,"median":3.0801,"eighty":7.62201,"marketCap":3280928609},{"date":"2024-10-04","current":7.686227,"twenty":-10.635885,"median":3.097075,"eighty":7.668336,"marketCap":3243264888},{"date":"2024-10-11","current":7.834992,"twenty":-10.635885,"median":3.133196,"eighty":7.694477,"marketCap":3306037756},{"date":"2024-10-18","current":7.872184,"twenty":-10.635885,"median":3.155214,"eighty":7.749005,"marketCap":3321730974},{"date":"2024-10-25","current":7.435805,"twenty":-10.635885,"median":3.209618,"eighty":7.753419,"marketCap":3137597225},{"date":"2024-10-31","current":8.541869,"twenty":-10.635885,"median":3.232728,"eighty":7.761601,"marketCap":3231756528},{"date":"2024-11-08","current":10.339444,"twenty":-10.638499,"median":3.259831,"eighty":7.813587,"marketCap":3911856437},{"date":"2024-11-15","current":9.190464,"twenty":-10.638499,"median":3.349512,"eighty":7.829517,"marketCap":3477147598},{"date":"2024-11-22","current":10.06568,"twenty":-10.638499,"median":3.38558,"eighty":7.872401,"marketCap":3808279602},{"date":"2024-11-29","current":9.722783,"twenty":-10.638499,"median":3.436207,"eighty":7.907003,"marketCap":3678547000},{"date":"2024-12-06","current":9.213969,"twenty":-10.638499,"median":3.493783,"eighty":7.959307,"marketCap":3486040559},{"date":"2024-12-13","current":8.801939,"twenty":-10.638499,"median":3.56111,"eighty":7.998729,"marketCap":3330152190},{"date":"2024-12-20","current":7.723474,"twenty":-10.638499,"median":3.606796,"eighty":8.015391,"marketCap":2922122233},{"date":"2024-12-27","current":7.482893,"twenty":-10.638499,"median":3.652482,"eighty":8.015391,"marketCap":2831100165},{"date":"2025-01-03","current":7.527138,"twenty":-10.638499,"median":3.69336,"eighty":8.015391,"marketCap":2847839856},{"date":"2025-01-10","current":7.249225,"twenty":-10.641114,"median":3.763091,"eighty":8.01571,"marketCap":2742693675},{"date":"2025-01-17","current":7.516077,"twenty":-10.641114,"median":3.807574,"eighty":8.01571,"marketCap":2843654933},{"date":"2025-01-24","current":7.777397,"twenty":-10.641114,"median":3.823204,"eighty":8.01571,"marketCap":2942523731},{"date":"2025-01-31","current":7.391638,"twenty":-10.641114,"median":3.849654,"eighty":8.01571,"marketCap":2796574554},{"date":"2025-02-07","current":7.359837,"twenty":-10.641114,"median":3.926599,"eighty":8.01571,"marketCap":2784542901},{"date":"2025-02-14","current":11.29089,"twenty":-10.641114,"median":4.243374,"eighty":8.019246,"marketCap":2829530819},{"date":"2025-02-21","current":10.086516,"twenty":-10.641114,"median":4.394139,"eighty":8.037134,"marketCap":2527711235},{"date":"2025-02-28","current":10.426158,"twenty":-10.641114,"median":4.429258,"eighty":8.145007,"marketCap":2612826433},{"date":"2025-03-07","current":10.113771,"twenty":-10.643728,"median":4.464693,"eighty":8.287174,"marketCap":2534541467},{"date":"2025-03-14","current":10.126351,"twenty":-10.643728,"median":4.54681,"eighty":8.536641,"marketCap":2537693881},{"date":"2025-03-21","current":9.878343,"twenty":-10.643728,"median":4.631973,"eighty":8.801939,"marketCap":2475542323},{"date":"2025-03-28","current":10.547385,"twenty":-10.643728,"median":4.683872,"eighty":8.853227,"marketCap":2643206442},{"date":"2025-04-04","current":9.2093,"twenty":-10.643728,"median":4.802266,"eighty":9.064643,"marketCap":2307878204},{"date":"2025-04-11","current":9.17784,"twenty":-10.641114,"median":4.863283,"eighty":9.185414,"marketCap":2299994311},{"date":"2025-04-17","current":9.916094,"twenty":-10.641114,"median":4.957963,"eighty":9.291397,"marketCap":2485002994},{"date":"2025-04-25","current":10.524315,"twenty":-10.643728,"median":5.039055,"eighty":9.480855,"marketCap":2637424921},{"date":"2025-05-02","current":22.634497,"twenty":-10.643728,"median":5.095819,"eighty":9.629986,"marketCap":2386717131},{"date":"2025-05-09","current":22.574683,"twenty":-10.643728,"median":5.168875,"eighty":9.671535,"marketCap":2380410017},{"date":"2025-05-16","current":23.36223,"twenty":-10.643728,"median":5.214214,"eighty":9.722783,"marketCap":2463453687},{"date":"2025-05-23","current":22.335428,"twenty":-10.643728,"median":5.278206,"eighty":9.790675,"marketCap":2355181560},{"date":"2025-05-30","current":23.083099,"twenty":-10.643728,"median":5.313986,"eighty":9.852337,"marketCap":2434020488},{"date":"2025-06-06","current":23.222665,"twenty":-10.643728,"median":5.351129,"eighty":9.893342,"marketCap":2448737088},{"date":"2025-06-13","current":23.45195,"twenty":-10.643728,"median":5.376398,"eighty":9.974476,"marketCap":2472914359},{"date":"2025-06-20","current":23.432012,"twenty":-10.646342,"median":5.386128,"eighty":10.025155,"marketCap":2470811987},{"date":"2025-06-27","current":21.019527,"twenty":-10.646342,"median":5.417955,"eighty":10.06568,"marketCap":2216425048},{"date":"2025-07-03","current":24.927355,"twenty":-10.646342,"median":5.464788,"eighty":10.092806,"marketCap":2628489842},{"date":"2025-07-11","current":25.515523,"twenty":-10.646342,"median":5.4892,"eighty":10.134737,"marketCap":2690509799},{"date":"2025-07-18","current":26.258209,"twenty":-10.646342,"median":5.558087,"eighty":10.190842,"marketCap":2768823133},{"date":"2025-07-25","current":28.909949,"twenty":-10.646342,"median":5.623323,"eighty":10.226985,"marketCap":3048438530},{"date":"2025-08-01","current":25.610228,"twenty":-10.646342,"median":5.685122,"eighty":10.253762,"marketCap":2700496063},{"date":"2025-08-08","current":77.770471,"twenty":-10.646342,"median":5.702809,"eighty":10.328134,"marketCap":3137338569},{"date":"2025-08-15","current":80.259439,"twenty":-10.646342,"median":5.702809,"eighty":10.341849,"marketCap":3237746020},{"date":"2025-08-22","current":74.551753,"twenty":-10.646342,"median":5.702809,"eighty":10.406725,"marketCap":3007492284},{"date":"2025-08-29","current":76.688878,"twenty":-10.646342,"median":5.702809,"eighty":10.498414,"marketCap":3093706012},{"date":"2025-09-05","current":71.867317,"twenty":-10.648956,"median":5.691034,"eighty":10.571239,"marketCap":2899199431},{"date":"2025-09-12","current":77.184065,"twenty":-10.646342,"median":5.702809,"eighty":10.589689,"marketCap":3113682363},{"date":"2025-09-19","current":83.139344,"twenty":-10.646342,"median":5.702809,"eighty":10.589689,"marketCap":3353924274},{"date":"2025-09-26","current":83.686656,"twenty":-10.646342,"median":5.702809,"eighty":10.589689,"marketCap":3376003400},{"date":"2025-10-03","current":84.196172,"twenty":-10.646342,"median":5.702809,"eighty":10.589689,"marketCap":3396557779},{"date":"2025-10-10","current":85.395065,"twenty":-10.646342,"median":5.702809,"eighty":10.589689,"marketCap":3444922322},{"date":"2025-10-17","current":86.763367,"twenty":-10.646342,"median":5.702809,"eighty":10.752414,"marketCap":3500120986},{"date":"2025-10-24","current":81.707166,"twenty":-10.646342,"median":5.702809,"eighty":11.452336,"marketCap":3296148781},{"date":"2025-10-31","current":83.974638,"twenty":-10.646342,"median":5.702809,"eighty":11.654154,"marketCap":3387620852},{"date":"2025-11-07","current":121.515799,"twenty":-10.646342,"median":5.702809,"eighty":11.654154,"marketCap":4273953682},{"date":"2025-11-14","current":120.140712,"twenty":-10.646342,"median":5.702809,"eighty":11.654154,"marketCap":4225589139},{"date":"2025-11-21","current":109.214753,"twenty":-10.646342,"median":5.702809,"eighty":11.654154,"marketCap":3841301298},{"date":"2025-11-28","current":117.016875,"twenty":-10.646342,"median":5.702809,"eighty":11.654154,"marketCap":4115717513},{"date":"2025-12-05","current":123.473803,"twenty":-10.646342,"median":5.702809,"eighty":11.654154,"marketCap":4342820587},{"date":"2025-12-12","current":125.730738,"twenty":-10.646342,"median":5.702809,"eighty":11.654154,"marketCap":4422201522},{"date":"2025-12-19","current":127.793368,"twenty":-10.646342,"median":5.702809,"eighty":11.654154,"marketCap":4494748338},{"date":"2025-12-26","current":133.263821,"twenty":-10.646342,"median":5.702809,"eighty":11.654154,"marketCap":4687155108},{"date":"2026-01-02","current":131.784108,"twenty":-10.646342,"median":5.702809,"eighty":11.654154,"marketCap":4635110654},{"date":"2026-01-09","current":142.904373,"twenty":-10.646342,"median":5.702809,"eighty":11.654154,"marketCap":5026232615},{"date":"2026-01-16","current":153.112896,"twenty":-10.646342,"median":5.702809,"eighty":11.654154,"marketCap":5385286780},{"date":"2026-01-23","current":146.969846,"twenty":-10.646342,"median":5.702809,"eighty":11.654154,"marketCap":5169223439},{"date":"2026-01-30","current":137.643173,"twenty":-10.646342,"median":5.702809,"eighty":11.654154,"marketCap":4841185666},{"date":"2026-02-06","current":129.31792,"twenty":-10.646342,"median":5.702809,"eighty":11.654154,"marketCap":4548369897},{"date":"2026-02-13","current":79.402167,"twenty":-10.646342,"median":5.702809,"eighty":11.654154,"marketCap":4525764730},{"date":"2026-02-20","current":78.867224,"twenty":-10.646342,"median":5.702809,"eighty":11.654154,"marketCap":4495274039},{"date":"2026-02-27","current":78.101702,"twenty":-10.509096,"median":5.744819,"eighty":11.972274,"marketCap":4451640810},{"date":"2026-03-06","current":73.167312,"twenty":2.307159,"median":5.792624,"eighty":12.26645,"marketCap":4170390475},{"date":"2026-03-13","current":78.71043,"twenty":2.371293,"median":5.887213,"eighty":12.694032,"marketCap":4486337113},{"date":"2026-03-20","current":83.580258,"twenty":2.424599,"median":5.932688,"eighty":12.84112,"marketCap":4763907536},{"date":"2026-03-27","current":88.191837,"twenty":2.485403,"median":6.114522,"eighty":12.971104,"marketCap":5026758316},{"date":"2026-04-02","current":84.760822,"twenty":2.509556,"median":6.171272,"eighty":13.066882,"marketCap":4831197336},{"date":"2026-04-10","current":79.042464,"twenty":2.552551,"median":6.226631,"eighty":13.172923,"marketCap":4505262369},{"date":"2026-04-17","current":79.153142,"twenty":2.571191,"median":6.293494,"eighty":13.569718,"marketCap":4511570787},{"date":"2026-04-24","current":81.735626,"twenty":2.58141,"median":6.382855,"eighty":21.019527,"marketCap":4658767224},{"date":"2026-05-01","current":34.350459,"twenty":2.606173,"median":6.412672,"eighty":22.12608,"marketCap":4723428516},{"date":"2026-05-08","current":33.730098,"twenty":2.61508,"median":6.449371,"eighty":22.594621,"marketCap":4638124517},{"date":"2026-05-15","current":32.973628,"twenty":2.62533,"median":6.483165,"eighty":22.958487,"marketCap":4534104648},{"date":"2026-05-22","current":32.81235,"twenty":2.640324,"median":6.53039,"eighty":23.292447,"marketCap":4511927823},{"date":"2026-05-29","current":40.158169,"twenty":2.664782,"median":6.570071,"eighty":23.436,"marketCap":5522029395},{"date":"2026-06-05","current":40.676562,"twenty":2.683392,"median":6.620662,"eighty":23.621422,"marketCap":5593312046},{"date":"2026-06-12","current":36.103185,"twenty":2.691532,"median":6.659095,"eighty":23.875631,"marketCap":4964440655},{"date":"2026-06-18","current":36.506379,"twenty":2.699886,"median":6.729135,"eighty":24.060056,"marketCap":5019882717},{"date":"2026-06-26","current":32.585793,"twenty":2.710794,"median":6.782062,"eighty":24.441867,"marketCap":4480774665},{"date":"2026-07-02","current":30.051428,"twenty":2.716286,"median":6.839502,"eighty":24.969225,"marketCap":4132281702},{"date":"2026-07-10","current":30.362464,"twenty":2.729353,"median":6.894078,"eighty":25.621194,"marketCap":4175051293},{"date":"2026-07-17","current":30.888536,"twenty":2.740192,"median":6.984363,"eighty":26.294097,"marketCap":4247389984},{"date":"2026-07-24","current":31.122773,"twenty":2.753077,"median":7.052656,"eighty":28.519167,"marketCap":4279599182},{"date":"2026-07-31","current":30.873177,"twenty":2.760491,"median":7.111923,"eighty":29.904937,"marketCap":4245277905},{"date":"2026-08-07","current":21.575307,"twenty":2.775555,"median":7.17005,"eighty":30.314849,"marketCap":4732112013},{"date":"2026-08-14","current":22.721292,"twenty":2.790045,"median":7.218068,"eighty":30.314849,"marketCap":4983460971},{"date":"2026-08-21","current":24.883161,"twenty":2.801555,"median":7.24093,"eighty":30.314849,"marketCap":5457623712},{"date":"2026-08-28","current":26.0628,"twenty":2.817918,"median":7.302928,"eighty":30.314849,"marketCap":5716353938},{"date":"2026-09-04","current":24.861494,"twenty":2.825715,"median":7.327839,"eighty":30.314849,"marketCap":5452871524},{"date":"2026-09-11","current":24.471491,"twenty":2.842665,"median":7.3565,"eighty":30.314849,"marketCap":5367332143},{"date":"2026-09-17","current":22.321659,"twenty":2.849453,"median":7.376569,"eighty":30.314849,"marketCap":4895809506}],"updateTime":1789724224220},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HCC\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627555674","title":"Sirtex Medical's DOORwaY90 Study Demonstrates 100% Local Tumor Control with SIR-Spheres®, Setting a New Benchmark in Y-90 for HCC","url":"https://stock-news.laohu8.com/highlight/detail?id=2627555674","media":"prnewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627555674?lang=en_us&edition=fundamental","pubTime":"2026-04-13 21:00","pubTimestamp":1776085200,"startTime":"0","endTime":"0","summary":"The DOORwaY90 study met its prespecified co-primary endpoints, achieving a best overall response rate  of 99%. WOBURN, Mass., April 13, 2026 /PRNewswire/ --Sirtex Medical , a leading manufacturer of interventional oncology and embolization solutions, today announced landmark 12-month results from the DOORwaY90 study, the first pivotal, prospective, multicenter U.S. trial of Y-90 selective internal radiation therapy  using partition dosimetry in patients with unresectable hepatocellular carcinoma .The DOORwaY90 study met its prespecified co-primary endpoints, demonstrating a 90% complete response  rate and a best overall response rate  of 99%, as assessed by blinded independent central review. All evaluable patients responded to treatment, resulting in 100% local tumor control—one of the highest reported response outcomes in Y-90 therapy. Responses were durable, with 75% lasting beyond six months and a median duration of 295 days, reinforcing the potential of SIR-Spheres Y-90 resin micr","market":"nz","thumbnail":"https://mma.prnewswire.com/media/926923/Sirtex_Medical_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/926923/Sirtex_Medical_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/sirtex-medicals-doorway90-study-demonstrates-100-local-tumor-control-with-sir-spheres-setting-a-new-benchmark-in-y-90-for-hcc-302739680.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORR","ORR.AU","HCC","USA","BK7095","CR","BK4006","BK4161","SIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627489492","title":"Warrior Met Coal (HCC) Valuation Check After Sector Weakness And Analyst Downgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2627489492","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627489492?lang=en_us&edition=fundamental","pubTime":"2026-04-13 11:24","pubTimestamp":1776050667,"startTime":"0","endTime":"0","summary":"Warrior Met Coal (HCC) has come under pressure as investors react to weaker sentiment toward coking coal producers, worries about softer metallurgical coal demand, and tighter decarbonization scrutiny on steelmakers, alongside insider selling and valuation concerns.\nSee our latest analysis for Warrior Met Coal.\nThat sector driven pullback has left Warrior Met Coal’s share price with a 7 day share price return of 6.9% and a 90 day share price return decline of 11.8%, even though the 1 year...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2055000-choice2-main-header/1585186660639","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2055000-choice2-main-header/1585186660639"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-hcc/warrior-met-coal/news/warrior-met-coal-hcc-valuation-check-after-sector-weakness-a","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-hcc/warrior-met-coal/news/warrior-met-coal-hcc-valuation-check-after-sector-weakness-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HCC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626215188","title":"Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Biliary Tract Cancer Following Positive Safety and Preliminary Efficacy Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2626215188","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626215188?lang=en_us&edition=fundamental","pubTime":"2026-04-09 16:34","pubTimestamp":1775723640,"startTime":"0","endTime":"0","summary":"NANJING, China, April  09, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) announced that its proprietary PD-L1/4-1BB bispecific antibo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/09/3270693/0/en/Leads-Biolabs-Opamtistomig-PD-L1-4-1BB-Bispecific-Antibody-Advances-to-Expansion-Phase-in-First-Line-Biliary-Tract-Cancer-Following-Positive-Safety-and-Preliminary-Efficacy-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2048586759.USD","LU1169590202.USD","ODD","IE00B2PGVK34.USD","OC","PD","LU1169589451.USD","IE0009354923.USD","BK4023","BK4006","LU2298321311.HKD","LU1917777945.USD","LU1974910355.USD","HCC","IE00BGHQF417.EUR","ORR","LU2092937221.SGD","LU2360108059.USD","LU0868494617.USD","LU2023250843.SGD","LU2106854487.HKD","BK4086","IE00B3CCJ633.GBP","LU2041044095.USD","LU2023250504.SGD","BK4183","BTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626971094","title":"Warrior Met Coal (HCC) Receives a Hold from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2626971094","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626971094?lang=en_us&edition=fundamental","pubTime":"2026-04-09 09:53","pubTimestamp":1775699592,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Sam Crittenden maintained a Hold rating on Warrior Met Coal on April 7 and set a price target of $90.00. The company’s shares c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/warrior-met-coal-hcc-receives-a-hold-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/warrior-met-coal-hcc-receives-a-hold-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCC","LU0029864427.USD","LU1267930573.SGD","BK4207","LU0128525929.USD","LU0310800379.SGD","BK4006","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625428219","title":"Press Release: Warrior Sets Date for First Quarter 2026 Earnings Announcement and Investor Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2625428219","media":"Dow Jones","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625428219?lang=en_us&edition=fundamental","pubTime":"2026-04-08 21:30","pubTimestamp":1775655000,"startTime":"0","endTime":"0","summary":"Warrior Met Coal, Inc.  today announced that it will hold its first quarter 2026 investor conference call at 4:30 p.m. ET on Thursday, April 30, 2026. Warrior will release its results following the close of market trading that afternoon.Telephone playback will also be available beginning at 6:30 p.m. ET on April 30, 2026, until 6:30 p.m. ET on May 7, 2026. The replay will be available by calling: 1-855-669-9658  or 1-412-317-0088  and entering passcode 4252718.CONTACT:    Analysts and Investors, contact: Dale W. Boyles,  554-6129","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","HCC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625613222","title":"Do Analyst Downgrades And Weaker Coal Outlook Change The Bull Case For Warrior Met Coal (HCC)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2625613222","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625613222?lang=en_us&edition=fundamental","pubTime":"2026-04-04 22:19","pubTimestamp":1775312388,"startTime":"0","endTime":"0","summary":"In recent days, analyst downgrades for Warrior Met Coal have cut consensus earnings estimates for 2026 and 2027, reflecting mounting concerns about weaker demand for coal amid the global shift toward cleaner energy and tightening environmental regulations.\nThis reassessment of Warrior Met Coal’s earnings outlook, coupled with a bearish industry stance from Zacks Equity Research, highlights how sector-wide decarbonization pressures may be reshaping expectations for the company’s long-term...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2055000-choice2-main-header/1585186660639","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2055000-choice2-main-header/1585186660639"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-hcc/warrior-met-coal/news/do-analyst-downgrades-and-weaker-coal-outlook-change-the-bul","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-hcc/warrior-met-coal/news/do-analyst-downgrades-and-weaker-coal-outlook-change-the-bul","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HCC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624954487","title":"Press Release: Adagene Reports Full Year 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2624954487","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624954487?lang=en_us&edition=fundamental","pubTime":"2026-04-02 05:00","pubTimestamp":1775077200,"startTime":"0","endTime":"0","summary":"In 2025, muzastotug showed 29% confirmed overall response rate  among 21 patients with MSS CRC in the 20 mg/kg dose cohorts. Median overall survival  for the 10 mg/kg cohorts was 19.4 months, with a median follow-up of 17.8 months. 4% overall discontinuation rate, no dose limiting toxicities, and no Grade 4 or 5 treatment-related adverse events  across 67 patients in all dose cohorts supports improved tolerability profile of muzastotug. Randomized Phase 2 trial enrollment ahead of plan, with potential updates in 2026 and results expected in 1H 2027; registration trial expected to begin once optimal dose regimen has been established. Cash and cash equivalents of $74.5 million as of December 31, 2025, plus proceeds raised from the ATM Offering in 2026 year-to-date, anticipated to provide cash runway into early 2028. SAN DIEGO, Calif. and SUZHOU, China, April 01, 2026  -- Adagene Inc.  , a platform-driven, clinical-stage biotechnology company transforming the discovery and development of ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4097","OS","BK4006","BK4022","HCC","ADAG","BK4139","R","ORR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624324537","title":"Press Release: Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2624324537","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624324537?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:01","pubTimestamp":1774987260,"startTime":"0","endTime":"0","summary":"Results from healthy volunteer study of next-generation STAT3 inhibitor, TTI-109, on track for Q2 2026. Topline data from Phase 2 trial of TTI-101 in hepatocellular carcinoma  are anticipated in H2 2026. Cash runway expected to be sufficient to fund operations into Q4 2026 after clinical readouts. TTI-101 was associated with a 9.4% baseline-weighted reduction in. TTI-109, is ongoing, with topline data anticipated in the second quarter. \"Further analysis of data from our Phase 2 IPF trial of TTI-101 that we announced in October revealed compelling trends. These data give us optimism for TTI-109, which has been developed to enhance TTI-101's ability to target STAT3 as a more efficient delivery vehicle with the potential to improve tolerability.\". \"At the same time, we eagerly await data from our ongoing Phase 2 REVERT LIVER CANCER trial, with a data readout expected in the second half of this year to allow for further data maturation. Interim results from this study have already shown cl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCC","LENZ","BK4539","BK4006","TVRD","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623338326","title":"Coal Stocks Have (Mostly) Benefited from the Iran War. This One Is Falling Like a Rock. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2623338326","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623338326?lang=en_us&edition=fundamental","pubTime":"2026-03-31 03:45","pubTimestamp":1774899900,"startTime":"0","endTime":"0","summary":"While coal stocks have broadly advanced since the start of the U.S. and Israel-led war with Iran, Peabody Energy shares sank Monday after the coal pure play announced that first-quarter shipment volumes from a mine will be lower than previously expected.The leading global supplier of coal reported in regulatory filings Monday that \"based on recent events\" around mine commissioning challenges, it forecasts shipments of 250,00 tons from its Centurion mine in Australia compared with prior forecasts of around 700,000 tons.Peabody Energy kept its full-year 2026 shipment targets for metallurgical coal, a critical component in blast-furnace steel production, unchanged at 10.3 million tons to 11.3 million tons.The stock, which had risen 25% since the start of the war entering into Monday, sank 11% to $35.17. The S&P 500 fell 0.7% and the Dow Jones Industrial Average was down 0.1% on Monday.Fellow coal stocks Core Natural Resources, Alpha Metallurgical Resources, and Warrior Met Coal have also ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","BK4588","CNR","HCC","VDE","AMR","BTU","BK4156","BK4585","BK4086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623345052","title":"Press Release: Harbour BioMed Reports Full Year 2025 Financial Results: Sustained Global Collaboration Underpins Long-Term Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2623345052","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623345052?lang=en_us&edition=fundamental","pubTime":"2026-03-30 21:54","pubTimestamp":1774878840,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 30, 2026 /PRNewswire/ -- Harbour BioMed , a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced its financial results for the year ended December 31, 2025.Dr. Jingsong Wang, Founder, Chairman, and CEO of Harbour BioMed, commented: \"2025 marked a pivotal year for Harbour BioMed as we entered the third phase of our strategic evolution, with a clear roadmap toward our 2028 vision of becoming a global leading platform-based biopharmaceutical group.The Company's strategy is powered by three integrated growth engines. These include building a global leading AI-driven antibody discovery 'new infrastructure' through Nona Biosciences, expanding global partnerships through platform-based collaborations with multinational pharmaceutical companies, and unlocking the global value of its mid- to late-stage pipeline in immunology,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4233","BK1583","BK4097","BK1161","BK4205","NEN","HCC","BK4006","BK4232","LU0266512127.USD","BK4113","02142","LU0456854461.SGD","ORR","BK4213","OS","CRC","BK1574","BK4590","TSLP","R","BK4022","MSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623141593","title":"Can-Fite’s Partner Vetbiolix Completes Enrollment in Phase 2 Osteoarthritis Study in Dogs Treated with Piclidenoson; Data Expected in Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2623141593","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623141593?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:20","pubTimestamp":1774869600,"startTime":"0","endTime":"0","summary":"Can-Fite Signed a Deal Worth up to $325M with the Veterinary Company Vetbiolix Ramat Gan, Israel, March  30, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biot","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/30/3264512/0/en/Can-Fite-s-Partner-Vetbiolix-Completes-Enrollment-in-Phase-2-Osteoarthritis-Study-in-Dogs-Treated-with-Piclidenoson-Data-Expected-in-Q3-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCC","BK4006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622887653","title":"Warrior Met Coal Is Maintained at Buy by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2622887653","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622887653?lang=en_us&edition=fundamental","pubTime":"2026-03-27 23:49","pubTimestamp":1774626540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HCC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 27, 2026 11:49 ET (15:49 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","HCC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622822561","title":"Warrior Met Coal price target raised to $105 from $101 at UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2622822561","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622822561?lang=en_us&edition=fundamental","pubTime":"2026-03-27 21:15","pubTimestamp":1774617312,"startTime":"0","endTime":"0","summary":"UBS analyst George Eadie raised the firm’s price target on Warrior Met Coal (HCC) to $105 from $101 and keeps a Buy rating on the shares. Published...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/warrior-met-coal-price-target-raised-to-105-from-101-at-ubs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/warrior-met-coal-price-target-raised-to-105-from-101-at-ubs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MMAT","BK4588","LU1863844665.USD","HCC","BK4534","LU1863844749.USD","BK4006","LU3187612489.SGD","IE0034235071.USD","UBS","BK4118","BK4141","LU1829250122.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622811748","title":"Press Release: Akeso Reports Full-Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2622811748","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622811748?lang=en_us&edition=fundamental","pubTime":"2026-03-27 11:54","pubTimestamp":1774583640,"startTime":"0","endTime":"0","summary":"HONG KONG, March 26, 2026 /PRNewswire/ -- Akeso, Inc.   announced its 2025 annual results, highlighting a year of comprehensive, strategic leaps across all facets of its business.In 2025, Akeso achieved record commercial sales revenue of RMB3,033.1 million, a 51.48% year-on-year increase. All approved products and indications are now included in China's National Reimbursement Drug List . The strong commercial growth in 2025 was fueled by strong clinical validation and widespread adoption by both healthcare professionals and patients.By the end of 2025, several high-impact indications were added to the latest NRDL, including:. -- Cadonilimab: 1L gastric cancer and 1L cervical cancer. With stable pricing for core first-line  indications and improved hospital access, Akeso's commercial platform is positioned for a transformative 2026.As the world's first and only approved PD-1/VEGF bispecific antibody, ivonescimab solidified its global leadership in 2025 by iterating upon existing Standar","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2399975544.HKD","AGIX","BK4551","BK4587","BK4528","LU0417516738.SGD","LU0348783233.USD","LU1794554557.SGD","LU0348766576.USD","LU2476274720.SGD","AIPO","LU0634319403.HKD","CHAT","LU1961090484.USD","BK4006","BK4023","AI","09926","BK4585","LU0348784397.USD","BK4543","LU0348767384.USD","LU2488822045.USD","IE00B5MMRT66.SGD","BK4588","AIYY","LU0348735423.USD","LU0417516571.SGD","HCC","IE00B543WZ88.USD","BK1161","LU0348825331.USD","LU0540923850.HKD","SOC","LU0561508036.HKD","LU1720050803.USD","BK4213","IE00BPRC5H50.USD","LU2476274308.USD","LU0417516902.SGD","BK1574","LU0348827113.USD","LU2778985437.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622247863","title":"Press Release: CStone Announces 2025 Annual Results: Accelerated Expansion of Global Commercial Footprint and Efficient Advancement of Innovation Pipeline 2.0","url":"https://stock-news.laohu8.com/highlight/detail?id=2622247863","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622247863?lang=en_us&edition=fundamental","pubTime":"2026-03-26 21:32","pubTimestamp":1774531920,"startTime":"0","endTime":"0","summary":"-- The global, multicenter Phase I/II clinical trial of CS2009. Australia and China, and the Phase II IND application has been approved. in the US. CS2009 demonstrates an excellent safety profile with a >=Grade. 3 TRAE rate of 23%, along with broad-spectrum anti-tumor activity.Notably, monotherapy data in lung cancer are encouraging: in first-line. NSCLC patients with PD-L1 TPS >=50%, the ORR reached 90% with a DCR of. 100%, while the ORR was 25% in IO-pretreated NSCLC .Furthermore, significant benefits were observed in patients with heavily. pre-treated \"cold tumors,\" achieving an ORR of 40% in non-clear cell. renal cell carcinoma  and 33.3% in soft tissue sarcoma .-- The global Phase Ib multicenter trial of CS5001  is being. advanced rapidly and efficiently in Australia and China, with its R&D. progress ranking among the top two globally. In combination with R-CHOP. rate exceeds 90%, and the ORR reaches 100%. Additionally, the combination. complementing its successful NRDL renewal at","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","LU1169590202.USD","BK4007","BK4213","LU1093756168.USD","CC","IE00BYQQ9H92.USD","LU2487616109.SGD","LU1169589451.USD","CRC","LU0210528500.USD","BK1161","LU0456854461.SGD","BK4022","LU2413666699.HKD","BK4181","BK1574","PD","BK4588","LU0347712357.USD","BK4098","L","R","BK4218","BK4533","02616","BK4548","HCC","BK4121","LU1093756325.SGD","BK4107","IE00B5TLWC47.USD","ORR","LU1721428933.USD","IE00BFXG0V08.USD","MTD","BK4585","LU0266512127.USD","LU2413666426.HKD","PK","LU2211817866.USD","BK4232","PROC","BK4156","BK4023","BK4006","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622863932","title":"Press Release: Can-Fite Reports 2025 Financial Results and Ongoing Clinical Progress Highlighting Positive Data in Phase 2a Pancreatic cancer and 9 Years Cancer-Free Survival in Liver Cancer Patient","url":"https://stock-news.laohu8.com/highlight/detail?id=2622863932","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622863932?lang=en_us&edition=fundamental","pubTime":"2026-03-26 21:27","pubTimestamp":1774531620,"startTime":"0","endTime":"0","summary":"RAMAT GAN, Israel, March 26, 2026  -- Can-Fite BioPharma Ltd.  , a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today announced clinical updates and financial results for the year ended December 31, 2025 and early 2026.Phase 2a study in pancreatic cancer met its primary endpoint of safety in heavily pretreated patients. The study continues to follow patients for overall survival, with data maturing over time; currently more than 30% of patients are alive at last data cut-off.Motti Farbstein Can-Fite's CEO&CFO stated: \"The past months have marked a period of significant progress for Can-Fite, highlighted by encouraging clinical signals across multiple indications and continued expansion of our intellectual property portfolio. Notably, clinical observations in adva","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","LU2065732104.USD","BK4139","PRGS","CANF","HCC","BK4097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621770748","title":"Press Release: Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2621770748","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621770748?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:30","pubTimestamp":1774265400,"startTime":"0","endTime":"0","summary":"Strong financial position with cash, cash equivalents and marketable securities of $91.5M as of December 2025. $2.25B Moderna global settlement for infringement of lipid nanoparticle  delivery technology represents significant outcome for Arbutus and Genevant. Two additional patients from Phase 2a clinical trials of imdusiran achieve functional cure. Milestone payment received under Alnylam LNP license for product candidate to treat hepatocellular carcinoma . WARMINSTER, Pa., March 23, 2026  -- Arbutus Biopharma Corporation  , a clinical-stage biopharmaceutical company focused on infectious disease, today reported fourth quarter and year end 2025 financial results and provided a corporate update.\"We delivered another strong quarter, maintaining a disciplined approach to capital allocation and a continued focus on maximizing our cash runway,\" said Lindsay Androski, President and CEO of Arbutus. \"I am thrilled to announce that two additional patients from our Phase 2a trials of imdusiran","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCC","BK4006","BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":6,"totalSize":117,"code":"91000000","status":"200"}]}}